
SynTero Scientific is a pioneering University College London (UCL) spin-out commercializing breakthrough research in mechanochemistry and solvent-minimal synthesis. Built on a foundation of world-class academic excellence and cutting-edge reactor engineering, we bridge the gap between laboratory discovery and industrial manufacturing—delivering sustainable, scalable chemical processes and autonomous lab platforms for the pharmaceutical and chemical sectors.
CSO & Co-Founder
Professor Browne is a recognized global authority in mechanochemistry and enabling synthesis technologies at University College London (UCL). Backed by over 100 peer-reviewed publications and a decade of leadership in reactor engineering, he specializes in transforming solvent-minimized chemistry into commercially scalab
CSO & Co-Founder
Professor Browne is a recognized global authority in mechanochemistry and enabling synthesis technologies at University College London (UCL). Backed by over 100 peer-reviewed publications and a decade of leadership in reactor engineering, he specializes in transforming solvent-minimized chemistry into commercially scalable processes.
A proven innovator with licensed patents and extensive industrial collaborations—including work with Syngenta, Boehringer Ingelheim, and GSK—Professor Browne leads the company's strategic technical vision and drives the industrial adoption of sustainable chemical synthesis.
CEO & Co-Founder
Dr. Bolt brings over eight years of specialized expertise in mechanochemistry, twin-screw extrusion, and autonomous laboratory platforms. A UCL Ph.D. graduate and Innovate UK ICURe alumnus, his research demonstrated a groundbreaking 1,600-fold process scale-up
Backed by publications in green synthesis and organic process
CEO & Co-Founder
Dr. Bolt brings over eight years of specialized expertise in mechanochemistry, twin-screw extrusion, and autonomous laboratory platforms. A UCL Ph.D. graduate and Innovate UK ICURe alumnus, his research demonstrated a groundbreaking 1,600-fold process scale-up
Backed by publications in green synthesis and organic process chemistry, Dr. Bolt leads the company’s executive vision and R&D strategy, bridging academic innovation with scalable, industrial-grade manufacturing

Chairman
Dr. Lindsay is an accomplished life sciences executive and technology transfer specialist with a career spanning Oxford University, the Salk Institute, and Thermo Fisher Scientific. As the former CEO and co-founder of UCL spin-out Intract Pharma and co-founder of FabRx, alongside his role as a Sector Specialist for the UK Depart
Chairman
Dr. Lindsay is an accomplished life sciences executive and technology transfer specialist with a career spanning Oxford University, the Salk Institute, and Thermo Fisher Scientific. As the former CEO and co-founder of UCL spin-out Intract Pharma and co-founder of FabRx, alongside his role as a Sector Specialist for the UK Department for Business and Trade, he brings deep expertise in university spin-out creation, IP licensing, and global commercial strategy to drive our market development and industrial adoption.